MR1 Antikörper (AA 312-341) (APC)

Produktnummer ABIN1914621

Produktdetails anti-MR1 Antikörper (APC)

Target: MR1 (Major Histocompatibility Complex, Class I-Related (MR1))

Bindungsspezifität: AA 312-341

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MR1 Antikörper ist konjugiert mit APC

Applikation: ELISA, Western Blotting (WB)

Spezifität: This MR1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 312-341 amino acids from the C-terminal region of human MR1.

Aufreinigung: Protein A purified

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Approved: ELISA, WB

Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS, no preservatives added

Konservierungsmittel: Without preservative

Handhabung: Aliquot to avoid repeated freezing and thawing.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Haltbarkeit: 6 months

Details zu MR1

Target: MR1 (Major Histocompatibility Complex, Class I-Related (MR1))

Andere Bezeichnung: MR1 (MR1 Produkte)

Synonyme: YFV antikoerper, hlals antikoerper, MGC154362 antikoerper, MR1 antikoerper, DKFZp468C1823 antikoerper, HLALS antikoerper, H2ls antikoerper, Hlals antikoerper, MHC class I antigen YF5 antikoerper, major histocompatibility complex, class I-related antikoerper, major histocompatibility complex, class I-related L homeolog antikoerper, YF5 antikoerper, MR1 antikoerper, mr1.L antikoerper, mr1 antikoerper, Mr1 antikoerper

Hintergrund: Name/Gene ID: MR1

Synonyms: MR1, HLALS, MHC class I-like antigen MR-1

Gen-ID: 3140

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints